Akron Pharma, Inc. FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

  • Latest inspection NAI · Aug 12, 2025
  • No warning letters matched by name
Inspections 1 0 OAI
Recalls 11 0 Class I (0%)
Warning letters 0 None on file
510(k) clearances 0 None on file

Akron Pharma, Inc. has 11 FDA recalls, 1 inspection, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Akron Pharma, Inc." is on file.

What these totals cover: FDA records filed under the name "Akron Pharma, Inc." and its spelling variant "Akron Pharma".

Latest recall
D-0194-2025 · Class III · Dec 12, 2024
Latest inspection
Aug 12, 2025 · NAI

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls11Nov 11, 2026 (checked Nov 15, 2026, unchanged)File dated Nov 10, 2026Current
510(k) clearances0Nov 15, 2026File dated Nov 9, 2026Current
Inspections1Nov 16, 2026Newest record Nov 5, 2026Current
Compliance actions0Nov 2, 2026Newest record Oct 29, 2026Current

FDA record by year

Akron Pharma, Inc.'s FDA inspections, warning letters and recalls in each of the last 10 calendar years (2017 to 2026, 2026 so far).

Akron Pharma, Inc.: FDA inspections per year

2017: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2018: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2019: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2020: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2021: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2022: 0 inspections (0 OAI), 0 warning letters, 2 recall records (0 Class I) 2023: 0 inspections (0 OAI), 0 warning letters, 1 recall record (0 Class I) 2024: 0 inspections (0 OAI), 0 warning letters, 8 recall records (0 Class I) 2025: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2026: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I)
YearInspectionsOAIWarning lettersRecall recordsClass I
202600000
202510000
202400080
202300010
202200020
202100000
202000000
201900000
201800000
201700000

Inspections are counted by the date they ended, warning letters by the date FDA issued them and recall records by the recall start date. FDA lists one recall record per recalled product, so one recall event can add several.

Reviewing Akron Pharma, Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Akron Pharma, Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Recent recalls

11 recall records from Aug 4, 2022 to Dec 12, 2024.

NumberClassProductDate
D-0194-2025Class IIIAcetaminophen Regular Strength, 325 mg, 100 Tablets per bottle, Akron Pharma, Inc., 373 RT US 46 W…Dec 12, 2024
D-0198-2025Class IIIDiphenhydramine HCl 25 mg, 1000 Capsules per bottle, Akron Pharma, Manufactured for: Akron Pharma…Dec 12, 2024
D-0197-2025Class IIIDiphenhydramine HCl 25 mg, 100 capsules per bottle, Akron Pharma, Manufactured for: Akron Pharma…Dec 12, 2024
D-0196-2025Class IIIAcetaminophen Extra Strength 500 mg, 1000 Tablets per bottle, Akron Pharma, Manufactured for: Akron…Dec 12, 2024
D-0195-2025Class IIIAcetaminophen, 325 mg Tablets, 100 Tablets per bottle, Akron Pharma, Manufactured for: Akron Pharma…Dec 12, 2024
D-0199-2025Class IIIDiphenhydramine HCl 50 mg, 1000 capsules per bottle, Akron Pharma, Manufactured for: Akron Pharma…Dec 12, 2024
D-0193-2025Class IIIAcetaminophen Extra Strength 500 mg, 100 Tablets per bottle, Akron Pharma, Inc., 373 RT US 46 W…Dec 12, 2024
D-0025-2025Class IIOneLAX Docusate Sodium Liquid (docusate sodium 50 mg/5 mL) Stool Softener Laxative, 16 FL OZ (473…Oct 15, 2024
D-0454-2023Class IIIDIBUCAINE 1% HEMORRHOIDAL OINTMENT, 1 oz. (28 gm), Manufactured for: Akron Pharma Inc. Fairfield NJ…Feb 17, 2023
D-1353-2022Class IIIAcetaminophen 500 mg tablet, Extra Strength, packaged in a) 100-count bottle (NDC 71399-8022-01), b)…Aug 4, 2022
D-1352-2022Class IIIAcetaminophen 325 mg tablets, packaged in a) 100-count bottle (NDC 71399-8024-01); b) 1000-count…Aug 4, 2022

Recent FDA inspections

1 inspection on Aug 12, 2025.

DateSiteProductClassificationFEI
Aug 12, 2025Fairfield, NJFood/CosmeticsNo Action Indicated (NAI)3013943804
NAI
No objectionable conditions or practices were found during the inspection.
VAI
Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI
Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

FDA-inspected facilities

1 inspected site, newest inspection first.

FacilityLocationInspectionsLatest
FEI 3013943804Fairfield, NJ1Aug 12, 2025

Akron Pharma, Inc. and the FDA: common questions

Has Akron Pharma, Inc. received an FDA warning letter?

No FDA warning letter addressed to the name "Akron Pharma, Inc." is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.

Has Akron Pharma, Inc. received an FDA Form 483?

FDA has not published a Form 483 for "Akron Pharma, Inc." in its reading room. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect Akron Pharma, Inc.?

The most recent FDA inspection on file ended Aug 12, 2025 at Fairfield, NJ and was classified NAI. FDA has 1 inspection of Akron Pharma, Inc. on file.

Has Akron Pharma, Inc. had an FDA recall?

Yes. Akron Pharma, Inc. has 11 FDA recalls on record. The most recent started Dec 12, 2024.

Need more than this page shows? Ask about Akron Pharma, Inc. in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.

Get a free API key

Prefer a PDF? Request a free supplier snapshot.

Is this your company or a supplier you list? Link to this FDA record from your site with a free button.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.